Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2017, Article ID 6138105, 11 pages
https://doi.org/10.1155/2017/6138105
Research Article

Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient’s Characteristics

Department of Gastroenterology, University Hospital of Larissa, Mezourlo 1, 41110 Larissa, Greece

Correspondence should be addressed to Konstantinos Argyriou; ku.gro.srotcod@2ransok

Received 22 January 2017; Revised 8 May 2017; Accepted 15 May 2017; Published 29 May 2017

Academic Editor: Michael Beyak

Copyright © 2017 Konstantinos Argyriou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Bannaga and C. P. Selinger, “Inflammatory bowel disease and anxiety: links, risks, and challenges faced,” Clinical and Experimental Gastroenterology, vol. 8, pp. 111–117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Lönnfors, S. Vermeire, M. Greco, D. Hommes, C. Bell, and L. Avedano, “IBD and health-related quality of life—discovering the true impact,” Journal of Crohn's and Colitis, vol. 8, no. 10, pp. 1281–1286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-F. Colombel, “Measuring disability in IBD: the IBD disability index,” Gastroenterology & Hepatology, vol. 9, no. 5, pp. 300–302, 2013. View at Google Scholar · View at Scopus
  4. T. Bernklev, J. Jahnsen, M. Henriksen et al., “Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 12, no. 5, pp. 402–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. P. Abraham and J. H. Sellin, “Disability in inflammatory bowel disease,” Gastroenterology Clinics of North America, vol. 41, no. 2, pp. 429–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ramos, X. Calvet, B. Sicilia et al., “IBD-related work disability in the Community: prevalence, severity and predictive factors. A cross-sectional study,” United European Gastroenterology Journal, vol. 3, no. 4, pp. 335–42, 2015. View at Google Scholar
  7. M. E. van der Valk, M.-J. J. Mangen, M. Leenders et al., “Risk factors of work disability in patients with inflammatory bowel disease—a Dutch nationwide web-based survey. Work disability in inflammatory bowel disease,” Journal of Crohn's and Colitis, vol. 8, no. 7, pp. 590–597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Zand, W. K. Van Deen, E. K. Inserra et al., “Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact,” Inflammatory Bowel Diseases, vol. 21, no. 7, pp. 1623–1630, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Schwartz, D. Greenberg, E. Chernin et al., “P592. Absenteeism and presenteeism amongst Crohn’s disease patients: results from a real-world cohort in Israel,” Journal of Crohn's and Colitis, vol. 10, supplement 1, pp. S400–S400, 2016. View at Publisher · View at Google Scholar
  10. D. T. Rubin, C. A. Siegel, S. V. Kane et al., “Impact of ulcerative colitis from patients' and physicians' perspectives: results from the UC: NORMAL survey,” Inflammatory Bowel Diseases, vol. 15, no. 4, pp. 581–588, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Ghosh, “Inflammatory bowel disease: appreciating disability and impact of disease,” Canadian Journal of Gastroenterology and Hepatology, vol. 29, article 66, no. 2, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. “Toward a common language for Functioning, disability and health. ICF,” World Health Organization, Geneva, Switzerland 2002 http://www.worldenablenet/escapstats/icfcommon.htm.
  13. C. Gower-Rousseau, H. Sarter, G. Savoye et al., “Validation of the inflammatory bowel disease Disability Index in a population-based cohort,” Gut, vol. 66, no. 4, pp. 588–596, 2017. View at Publisher · View at Google Scholar
  14. P. B. Allen, M. A. Kamm, L. Peyrin-Biroulet et al., “Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease,” Alimentary Pharmacology & Therapeutics, vol. 37, no. 4, pp. 438–444, 2013. View at Publisher · View at Google Scholar
  15. T. B. Üstün, N. Kostanjsek, S. Chatterji et al., “Measuring Health and disability: Manual for Disability Assessment Schedule (WHODAS 2.0) World Health Organization,” http://www.who.int/classifications/icf/whodasii/en/.
  16. E. Israeli, LA. Graff, I. Clara et al., “Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis,” Clinical Gastroenterology and Hepatology, vol. 12, no. 8, pp. 1330–1337, 2014. View at Publisher · View at Google Scholar
  17. “Inflammatory bowel disease. World Gastroenterology Organisation Global Guidelines,” http://www.worldgastroenterology.org/UserFiles/file/guidelines/inflammatory-bowel-disease-english-2015.pdf.
  18. R. F. Harvey and J. M. Bradshaw, “A simple index of Crohn's-disease activity,” The Lancet, vol. 1, article 514, no. 8167, 1980. View at Google Scholar · View at Scopus
  19. R. S. Walmsley, R. C. S. Ayres, R. E. Pounder, and R. N. Allan, “A simple clinical colitis activity index,” Gut, vol. 43, no. 1, pp. 29–32, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. A. G. Pallis, I. G. Vlachonikolis, and I. A. Mouzas, “Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the Inflammatory Bowel Disease Questionnaire,” Digestion, vol. 63, no. 4, pp. 240–246, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. C. J. Hawkey, M. Allez, M. M. Clark et al., “Autologous hematopoetic stem cell transplantation for refractory Crohn disease a randomized clinical trial,” JAMA, vol. 314, no. 23, pp. 2524–2534, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Tsoukka, E. Jelastopulu, G. Lavranos et al., “Estimation of quality of life in Cypriot patients with inflammatory bowel disease,” World Journal of Gastroenterology, vol. 23, no. 1, pp. 121–126, 2017. View at Publisher · View at Google Scholar
  23. A.-C. Lesage, H. Hagège, G. Tucat, and J.-P. Gendre, “Results of a national survey on quality of life in inflammatory bowel diseases,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 2, pp. 117–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. R. Muller, R. Prosser, P. Bampton, R. Mountifield, and J. M. Andrews, “Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions,” Inflammatory Bowel Diseases, vol. 16, no. 4, pp. 657–663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. H. M. Becker, D. Grigat, S. Ghosh et al., “Living with inflammatory bowel disease: a Crohn's and Colitis Canada survey,” Canadian Journal of Gastroenterology and Hepatology, vol. 29, no. 2, pp. 77–84, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Viazis, G. Mantzaris, K. Karmiris et al., “Inflammatory bowel disease: Greek patients' perspective on quality of life, information on the disease, work productivity and family support,” Annals of Gastroenterology, vol. 26, no. 1, pp. 52–58, 2013. View at Google Scholar
  27. P. Hendy, Y. Inspector, and A. Hart, “Standard medical care, side effects and compliance,” in Psychological Aspects of Inflammatory Bowel Disease: a Biopsychosocial Approach, pp. 110-111, Routledge. Taylor and Francis Group, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Rosenblatt and S. Kane, “Sex-specific issues in inflammatory bowel disease,” Gastroenterology & Hepatology, vol. 11, no. 9, pp. 592–601, 2015. View at Google Scholar · View at Scopus
  29. T. Longobardi, P. Jacobs, and C. N. Bernstein, “Work losses related to Inflammatory bowel disease in the United States Folder: results from the National Health interview survey,” The American Journal of Gastroenterology, vol. 98, pp. 1064–1072, 2003. View at Google Scholar
  30. M. K. Vester-Andersen, M. V. Prosberg, I. Vind, M. Andersson, T. Jess, and F. Bendtsen, “Low risk of unemployment, sick leave, and work disability among patients with inflammatory bowel disease: a 7-year follow-up study of a danish inception cohort,” Inflammatory Bowel Diseases, vol. 21, no. 10, pp. 2296–2303, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. B. G. Feagan, M. Bala, S. Yan, A. Olson, and S. Hanauer, “Unemployment and disability in patients with moderately to severely active Crohn's disease,” Journal of Clinical Gastroenterology, vol. 39, no. 5, pp. 390–395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. G. E. M. De Boer, F. B. Evertsz, P. C. Stokkers et al., “Employment status, difficulties at work and quality of life in inflammatory bowel disease patients,” European Journal of Gastroenterology and Hepatology, vol. 28, no. 10, pp. 1130–1136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. M. D. Mandel, A. Bálint, Lovász B. D. et al., “Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics,” European Journal of Health Economics, vol. 15, no. Suppl 1, S129 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Argyriou, A. Kapsoritakis, and S. Potamianos, “PTU-098high levels of emotional and physical distress among family caregivers of individuals with Inflammatory Bowel Disease (IBD),” Gut, vol. 63, supplement 1, article A82, 2014. View at Publisher · View at Google Scholar
  35. J. Devlen, K. Beusterien, L. Yen, A. Ahmed, A. S. Cheifetz, and A. C. Moss, “The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model,” Inflammatory Bowel Diseases, vol. 20, no. 3, pp. 545–552, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J. B. Soares, R. Pereira, J. M. Costa et al., “The inflammatory bowel disease-disability index: validation of the Portuguese version according to the COSMIN checklist,” European Journal of Gastroenterology & Hepatology, vol. 28, no. 10, pp. 1151–1160, Oct 2016. View at Google Scholar
  37. M. van der Have, H. H. Fidder, M. Leenders et al., “Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions,” Inflammatory Bowel Diseases, vol. 21, no. 2, pp. 369–377, 2015. View at Publisher · View at Google Scholar · View at Scopus